2 recruiting. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
| Phase 3 | 1 | Recruiting 1 |
Follow Kncv Tuberculosis Foundation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB Ganfeborole, BTZ-043, Bedaquiline (B) - Pulmonary Tuberculosis | Phase 2 | Recruiting | University College, London | 2500 | 2024-01-09 | 2026-10-15 |
| DeMONSTRATE-TB Study in Ethiopia Enhanced community-wide TB intervention, Routine TB program activities - Reducing Tuberculosis Incidence | Phase 2 / Phase 3 | Recruiting | Management Sciences for Health | 131438 | 2023-02-27 | 2024-12-05 |
2-(2-methyl-1,4-dioxa-8-azaspiro(4.5)dec-8-yl)-8-nitro-6-(trifluoromethyl)-4H-1,3-benzothiazin-4-one (1) · Ethambutol (1) · Fumigant 93 (1) · GSK656 (1) · Isoniazid (1) · Linezolid (1) · Moxifloxacin (1) · OPC-67683 (1) · Protons (1) · Pyrazinamide (1) · Rifampin (1) · bedaquiline (1) · delpazolid (1) · pretomanid (1)
Ethiopia (1) · Moldova (1) · South Africa (1) · Tanzania (1) · Uganda (1) · Vietnam (1)